A federal judge in West Virginia this week dismissed approximately 378 recently settled lawsuits against Boston Scientific (NYSE:BSX) over supposed defective pelvic mesh implants, according to court documents released yesterday.
Pelvic mesh implants are used to treat pelvic organ prolapse and female stress urinary incontinence, and have been the source of a number of lawsuits which claim the devices have caused lasting damage to the individuals they are implanted in.
The Marlborough, Mass.-based company and the plaintiffs filed joint motions looking to dismiss the cases with prejudice on Wednesday, according to court documents, bringing an end to cases that had been in process for nearly 5 years.
No details were released as to the amounts offered in the settlements, and Boston Scientific has not yet provided any comment on the settled cases.
Boston Scientific has seen a mixed bag in terms of pelvic mesh suits over the past year.
In October, a federal appeals court upheld a plaintiff’s $27 million win over Boston Scientific in a product liability lawsuit brought over its Pinnacle pelvic mesh. But in May, a federal appeals court upheld a win for Boston Scientific in a product liability lawsuit brought over its Uphold pelvic mesh.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.